Stay updated on Safety of Iptacopan in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the Safety of Iptacopan in IgA Nephropathy Clinical Trial page.
Latest updates to the Safety of Iptacopan in IgA Nephropathy Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe website has been updated to version 2.11.2 on October 1, 2024, following the removal of version 2.11.0 from August 5, 2024.SummaryDifference1.0%
- Check22 days agoChange DetectedThe website has been updated to Revision v2.11.0, while the previous version v2.10.5 has been removed, along with a notice regarding delays in study record information display.SummaryDifference4%
- Check30 days agoChange DetectedClinicalTrials.gov is addressing delays in displaying study record information, and the site has been updated to version 2.10.5, replacing the previous version 2.10.3.SummaryDifference4%
- Check44 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3.SummaryDifference0.3%
- Check65 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.3%
- Check72 days agoChange DetectedA new addition was made on August 5, 2024, while a previous entry was deleted on July 8, 2024.SummaryDifference0.7%
Stay in the know with updates to Safety of Iptacopan in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Iptacopan in IgA Nephropathy Clinical Trial page.